Australia's most trusted
source of pharma news
Friday, 19 April 2024
Posted 19 January 2022 AM
Dr Gisela Mautner has been named Noxopharm's new CEO ahead of an "important growth phase", taking over next month from the company's founder Dr Graham Kelly who will remain on the board.
Kelly who founded the Sydney-based biotech back in 2015 said, "the company is in the process of transitioning from an early-stage biotech company into a serious bio-pharma company looking to make its mark on the world stage.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.